Display options
Cite
Morra G, Neves MA, Plescia CJ, et al. Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90. J Chem Theory Comput. 2010;6(9):2978-89doi: 10.1021/ct100334n.
Morra, G., Neves, M. A., Plescia, C. J., Tsustsumi, S., Neckers, L., Verkhivker, G., Altieri, D. C., & Colombo, G. (2010). Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90. Journal of chemical theory and computation, 6(9), 2978-89. https://doi.org/10.1021/ct100334n
Morra, Giulia, et al. "Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90." Journal of chemical theory and computation vol. 6,9 (2010): 2978-89. doi: https://doi.org/10.1021/ct100334n
Morra G, Neves MA, Plescia CJ, Tsustsumi S, Neckers L, Verkhivker G, Altieri DC, Colombo G. Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90. J Chem Theory Comput. 2010 Sep 14;6(9):2978-89. doi: 10.1021/ct100334n. Epub 2010 Aug 30. PMID: 26616092; PMCID: PMC7575213.
Copy Download .nbib Format: NLM
Share it on

J Chem Theory Comput. 2010 Sep 14;6(9):2978-89. doi: 10.1021/ct100334n. Epub 2010 Aug 30.

Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90.

Journal of chemical theory and computation

Giulia Morra, Marco A C Neves, Christopher J Plescia, Shinji Tsustsumi, Len Neckers, Gennady Verkhivker, Dario C Altieri, Giorgio Colombo

Affiliations

  1. Istituto di Chimica del Riconoscimento Molecolare, CNR, Via Mario Bianco 9, 20131 Milano, Italy, Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, and Department of Pharmaceutical Chemistry, School of Pharmacy and Center for Bioinformatics, University of Kansas, Lawrence, Kansas 66047.

PMID: 26616092 PMCID: PMC7575213 DOI: 10.1021/ct100334n

Abstract

The study of allosteric functional modulation in dynamic proteins is attracting increasing attention. In particular, the discovery of new allosteric sites may generate novel opportunities and strategies for drug development, overcoming the limits of classical active-site oriented drug design. In this paper, we report on the results of a novel, ab initio, fully computational approach for the discovery of allosteric inhibitors based on the physical characterization of signal propagation mechanisms in proteins and apply it to the important molecular chaperone Hsp90. We first characterize the allosteric "hot spots" involved in interdomain communication pathways from the nucleotide-binding site in the N-domain to the distal C-domain. On this basis, we develop dynamic pharmacophore models to screen drug libraries in the search for small molecules with the functional and conformational properties necessary to bind these "hot spot" allosteric sites. Experimental tests show that the selected moelcules bind the Hsp90 C-domain, exhibit antiproliferative activity in different tumor cell lines, while not affecting proliferation of normal human cells, destabilize Hsp90 client proteins, and disrupt association with several cochaperones known to bind the N- and M-domains of Hsp90. These results prove that the hits alter Hsp90 function by affecting its conformational dynamics and recognition properties through an allosteric mechanism. These findings provide us with new insights on the discovery and development of new allosteric inhibitors that are active on important cellular pathways through computational biology. Though based on the specific case of Hsp90, our approach is general and can readily be extended to other target proteins and pathways.

References

  1. J Comput Chem. 2005 Dec;26(16):1701-18 - PubMed
  2. Cell. 2006 Oct 20;127(2):329-40 - PubMed
  3. Nature. 2007 Dec 13;450(7172):964-72 - PubMed
  4. Biochem J. 2008 Mar 15;410(3):439-53 - PubMed
  5. Nat Chem Biol. 2010 Mar;6(3):179-188 - PubMed
  6. J Chem Inf Model. 2005 Jan-Feb;45(1):177-82 - PubMed
  7. Biopolymers. 2010 Mar;93(3):211-7 - PubMed
  8. Mol Cell. 2007 Apr 13;26(1):27-39 - PubMed
  9. Curr Opin Struct Biol. 2004 Dec;14(6):706-15 - PubMed
  10. PLoS Comput Biol. 2009 Mar;5(3):e1000323 - PubMed
  11. PLoS Comput Biol. 2007 Sep;3(9):1716-26 - PubMed
  12. J Med Chem. 2009 Jan 8;52(1):143-50 - PubMed
  13. Nat Chem Biol. 2009 Nov;5(11):789-96 - PubMed
  14. Nature. 2007 Dec 13;450(7172):1001-9 - PubMed
  15. Science. 2009 Apr 10;324(5924):198-203 - PubMed
  16. J Mol Biol. 1998 Jul 31;280(5):925-32 - PubMed
  17. J Mol Graph. 1996 Feb;14(1):33-8, 27-8 - PubMed
  18. J Med Chem. 2010 Jan 14;53(1):3-17 - PubMed
  19. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16984-9 - PubMed
  20. J Am Chem Soc. 2005 Sep 21;127(37):12778-9 - PubMed
  21. Mol Cell. 2007 Oct 12;28(1):41-56 - PubMed
  22. Nat Struct Mol Biol. 2009 Nov;16(11):1141-7 - PubMed
  23. J Med Chem. 2007 Nov 29;50(24):6189-200 - PubMed
  24. Structure. 2009 Aug 12;17(8):1042-50 - PubMed
  25. Curr Opin Struct Biol. 2006 Feb;16(1):102-8 - PubMed
  26. Science. 2008 Oct 17;322(5900):438-42 - PubMed
  27. Science. 2010 Feb 5;327(5966):653-4 - PubMed
  28. Nature. 2006 Apr 20;440(7087):1013-7 - PubMed
  29. Nat Struct Biol. 2003 Jan;10(1):59-69 - PubMed
  30. J Med Chem. 1985 Jul;28(7):849-57 - PubMed

Publication Types

Grant support